BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23797868)

  • 1. Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status.
    Maxwell JH; Ferris RL; Gooding W; Cunningham D; Mehta V; Kim S; Myers EN; Johnson J; Chiosea S
    Cancer; 2013 Sep; 119(18):3302-8. PubMed ID: 23797868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.
    Haughey BH; Sinha P; Kallogjeri D; Goldberg RL; Lewis JS; Piccirillo JF; Jackson RS; Moore EJ; Brandwein-Gensler M; Magnuson SJ; Carroll WR; Jones TM; Wilkie MD; Lau A; Upile NS; Sheard J; Lancaster J; Tandon S; Robinson M; Husband D; Ganly I; Shah JP; Brizel DM; O'Sullivan B; Ridge JA; Lydiatt WM
    Oral Oncol; 2016 Nov; 62():11-19. PubMed ID: 27865363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV DNA genotyping, HPV E6*I mRNA detection, and p16
    Simoens C; Gorbaslieva I; Gheit T; Holzinger D; Lucas E; Ridder R; Rehm S; Vermeulen P; Lammens M; Vanderveken OM; Kumar RV; Gangane N; Caniglia A; Maffini F; Rubio MBL; Anantharaman D; Chiocca S; Brennan P; Pillai MR; Sankaranarayanan R; Bogers J; Pawlita M; Tommasino M; Arbyn M;
    Cancer Epidemiol; 2021 Jun; 72():101925. PubMed ID: 33839457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular Toll-Like Receptors Modulate Adaptive Immune Responses in Head and Neck Cancer.
    Nayanar SK; Roshan V G D; Surendran S; Kjeller G; Hasséus B; Giglio D
    Viral Immunol; 2023 Dec; 36(10):659-668. PubMed ID: 38064542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer.
    Dale OT; Aleksic T; Shah KA; Han C; Mehanna H; Rapozo DC; Sheard JD; Goodyear P; Upile NS; Robinson M; Jones TM; Winter S; Macaulay VM
    Carcinogenesis; 2015 Jun; 36(6):648-55. PubMed ID: 25896444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study.
    Hall SF; Liu FF; O'Sullivan B; Shi W; Rohland S; Griffiths R; Groome P
    Br J Cancer; 2017 Oct; 117(8):1105-1112. PubMed ID: 28829763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status.
    Du E; Mazul AL; Farquhar D; Brennan P; Anantharaman D; Abedi-Ardekani B; Weissler MC; Hayes DN; Olshan AF; Zevallos JP
    Laryngoscope; 2019 Nov; 129(11):2506-2513. PubMed ID: 30637762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of lymph node status in patients with surgically treated head and neck squamous cell carcinoma via neck lavage cytology: A pilot study.
    Rimbach H; Linxweiler M; Körner S; Smola S; Linxweiler B; Speicher S; Helfrich J; Solomayer EF; Wagner M; Schick B; Kühn JP
    Cancer Cytopathol; 2024 May; 132(5):285-296. PubMed ID: 38329321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials.
    Argiris A; Li S; Ghebremichael M; Egloff AM; Wang L; Forastiere AA; Burtness B; Mehra R
    Ann Oncol; 2014 Jul; 25(7):1410-1416. PubMed ID: 24799460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentric human papillomavirus-associated head and neck squamous cell carcinoma.
    Caley A; Evans M; Powell N; Paleri V; Tomkinson A; Urbano TG; Jay A; Robinson M; Thavaraj S
    Head Neck; 2015 Feb; 37(2):202-8. PubMed ID: 24375667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSMD1 as a prognostic marker and potential target in oropharyngeal cancer.
    Park HC; Kim H; Kim JY; Lee HY; Lee J; Cha W; Ahn SH; Jeong WJ
    BMC Cancer; 2023 Dec; 23(1):1242. PubMed ID: 38104103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the Number and Location of Lymph Node Metastasis in Oropharyngeal Cancer.
    Iida M; Murai T; Kuno M; Osumi K; Nakanishi-Imai M; Okazaki D; Murase T; Kawakita D; Iwasaki S; Inagaki H; Tomita N; Shibamoto Y; Hiwatashi A
    In Vivo; 2023; 37(5):2210-2218. PubMed ID: 37652496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma.
    Azzimonti B; Raimondo L; Squarzanti DF; Rosso T; Zanetta P; Aluffi Valletti P; Chiusa L; Masini L; Pecorari G; Airoldi M; Krengli M; Giovarelli M; Valente G
    Ann Med; 2021 Dec; 53(1):541-550. PubMed ID: 33769181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance of p16
    Mena M; Wang X; Tous S; Quiros B; Clavero O; Alejo M; Morey F; Taberna M; Leon Vintro X; Lloveras Rubio B; Alos L; Mehanna H; Quint W; Pawlita M; Tommasino M; Pavón MA; Muñoz N; De Sanjose S; Bosch FX; Alemany L; On Behalf Of The Ico International Hpv In Head And Neck Cancer Study Group
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples.
    Chen C; Lohavanichbutr P; Zhang Y; Houck JR; Upton MP; Abedi-Ardekani B; Agudo A; Ahrens W; Alemany L; Anantharaman D; Conway DI; Futran ND; Holcatova I; Günther K; Hansen BT; Healy CM; Itani D; Kjaerheim K; Monroe MM; Thomson PJ; Witt BL; Nakoneshny S; Peterson LA; Schwartz SM; Zarins KR; Hashibe M; Brennan P; Rozek LS; Wolf G; Dort JC; Wang P
    Oral Oncol; 2020 Jan; 100():104487. PubMed ID: 31835136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
    Kusters JMA; Diergaarde B; Ness A; Schim van der Loeff MF; Heijne JCM; Schroeder L; Hueniken K; McKay JD; Macfarlane GJ; Lagiou P; Lagiou A; Polesel J; Agudo A; Alemany L; Ahrens W; Healy CM; Conway DI; Robinson M; Canova C; Holcátová I; Richiardi L; Znaor A; Pring M; Thomas S; Hayes DN; Liu G; Hung RJ; Brennan P; Olshan AF; Virani S; Waterboer T
    Int J Cancer; 2024 Jan; 154(2):389-402. PubMed ID: 37694289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guide.
    Chu A; Genden E; Posner M; Sikora A
    Oncologist; 2013; 18(2):180-9. PubMed ID: 23345545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancer.
    Farquhar DR; Coniglio AJ; Masood MM; Lenze N; Brennan P; Anantharaman D; Abedi-Ardekani B; Zanation AM; Weissler MC; Olshan AF; Sheth S; Hackman TG
    Oral Oncol; 2020 Sep; 108():104800. PubMed ID: 32492516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma.
    Dhanda J; Triantafyllou A; Liloglou T; Kalirai H; Lloyd B; Hanlon R; Shaw RJ; Sibson DR; Risk JM
    Br J Cancer; 2014 Nov; 111(11):2114-21. PubMed ID: 25268377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A descriptive study of human papilloma virus in upper aero-digestive squamous cell carcinoma at Uganda cancer institute assessed by P16 immunohistochemistry.
    Kabagenyi F; Otiti J; Namwagala J; Kamulegeya A; Kalungi S
    Cancers Head Neck; 2020; 5():10. PubMed ID: 32864169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.